| 17.22 0.14 (0.82%) | 02-11 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 21.95 | 1-year : | 23.75 |
| Resists | First : | 18.8 | Second : | 20.34 |
| Pivot price | 17.3 |
|||
| Supports | First : | 16.3 | Second : | 13.56 |
| MAs | MA(5) : | 16.85  |
MA(20) : | 17.6 |
| MA(100) : | 17.71 |
MA(250) : | 20.25 |
|
| MACD | MACD : | -0.4 |
Signal : | -0.3 |
| %K %D | K(14,3) : | 24.1 |
D(3) : | 15.6 |
| RSI | RSI(14): 45.6 |
|||
| 52-week | High : | 26.39 | Low : | 15.27 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ KIDS ] has closed above bottom band by 45.9%. Bollinger Bands are 6.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 17.28 - 17.34 | 17.34 - 17.4 |
| Low: | 16.47 - 16.55 | 16.55 - 16.62 |
| Close: | 17.1 - 17.21 | 17.21 - 17.3 |
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and ApiFix Mid-C system. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.
Tue, 03 Feb 2026
OrthoPediatrics and iotaMotion Announce FDA Clearance for Expanded Pediatric Use of iotaSOFT® Insertion System - Quiver Quantitative
Tue, 03 Feb 2026
Robot-assisted cochlear implants now cleared for kids 4+ - Stock Titan
Tue, 03 Feb 2026
Brown Capital Management LLC Decreases Holdings in OrthoPediatrics Corp. $KIDS - MarketBeat
Tue, 13 Jan 2026
OrthoPediatrics (KIDS) Moves 9.8% Higher: Will This Strength Last? - Nasdaq
Mon, 12 Jan 2026
OrthoPediatrics Reports Record 2025 Revenue of $236.1 Million and Provides 2026 Financial Guidance - Quiver Quantitative
Mon, 12 Jan 2026
OrthoPediatrics Corp. Achieves Record Preliminary Unaudited - GlobeNewswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 25 (M) |
| Shares Float | 15 (M) |
| Held by Insiders | 32.7 (%) |
| Held by Institutions | 70.6 (%) |
| Shares Short | 1,010 (K) |
| Shares Short P.Month | 1,080 (K) |
| EPS | -1.97 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 13.93 |
| Profit Margin | -20.1 % |
| Operating Margin | -8 % |
| Return on Assets (ttm) | -4.1 % |
| Return on Equity (ttm) | -12.7 % |
| Qtrly Rev. Growth | 12.1 % |
| Gross Profit (p.s.) | 6.5 |
| Sales Per Share | 9.06 |
| EBITDA (p.s.) | -0.51 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -19 (M) |
| Levered Free Cash Flow | -12 (M) |
| PE Ratio | -8.79 |
| PEG Ratio | 0 |
| Price to Book value | 1.23 |
| Price to Sales | 1.89 |
| Price to Cash Flow | -22.51 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|